Compare CVS Health Corp (CVS) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs PAGSEG Inc — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while PAGSEG Inc trades at $8.91 (market cap $2.54B). The key difference: CVS Health Corp is far larger — about 48.2× PAGSEG Inc's market cap, and PAGSEG Inc pays the higher dividend (11.45%). Which is the better fit depends on your goals.
| CVS | PAGS | |
|---|---|---|
Market Cap | $122.36B | $2.54B |
Sector | Health | Technology |
52-Week High | $110.60 | $12.00 |
52-Week Low | $65.51 | $8.38 |
Enterprise Value | $184.71B | $10.31B |
Dividend Yield | 2.78% | 11.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
PAGS trades at $9.14, down 2.35% on the day, with a bearish technical signal from moving averages but oversold RSI conditions. The stock shows strong fundamentals with a P/E of 6.31, net income margin of 10.4%, and positive cash flow. Recent earnings have been mixed, with a miss in Q1 2026 but a beat in Q4 2025, while analyst sentiment remains largely positive.
The outlook for PAGS is cautiously optimistic, supported by deep value metrics and a consensus price target of $11.45, implying significant upside. Risks include competitive pressures in financial services and sensitivity to Brazilian interest rates, but robust profitability and aggressive capital returns provide a buffer against near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
